DRTS: Alpha Tau Medical Ltd. PEG Multiple

Corporate company logo of alphatau.com (DRTS)

Alpha Tau Medical Ltd. (DRTS) is developing patent-protected alpha-radiation technology to combat solid tumors. The growth-weighted P/E helps assess the asset's valuation relative to earnings dynamics, where the 0.00 mark indicates the current state. Alpha Tau Medical Ltd. (DRTS) is implementing energy-efficient systems with minimal use of hazardous metals, expanding its own laboratories in the US without engaging in third-party M&A transactions.

DRTS (Alpha Tau Medical Ltd.) PEG Multiple history from 04/28/2023 to 11/12/2026

Alpha Tau Medical Ltd. (DRTS) - metric breakdowns and financial figures

- current price and projected stock value:
Price Chart Alpha Tau Medical Ltd|DRTS - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Alpha Tau|DRTS - Total Company Value
- balance sheet equity data:
Equity per Share Alpha Tau Medical|DRTS - Book Capitalization|Market-to-Book Ratio alphatau.com|DRTS - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Debt to Capital Alpha Tau Medical Ltd.|DRTS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital alphatau.com|DRTS - Company Debts|Debts to Net Assets Alpha Tau|DRTS - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Alpha Tau Medical|Immediate Liquidity alphatau.com
- net income and valuation multiples indicators:
DRTS - Company Net Income|Net Profit Forecast Alpha Tau Medical Ltd.|DRTS - P/E Multiple|Projected Price to Earnings Alpha Tau Corp|DRTS - Price/Earnings to Growth Ratio|Company Value to EBITDA Alpha Tau|DRTS - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Alpha Tau Medical|DRTS - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months alphatau.com|DRTS - Earnings growth in current year|Net earnings per one share growth forecast for next year Alpha Tau Medical Ltd.
Fundamental company analysis:DRTS, Alpha Tau Medical Ltd
Mass-produced product of Alpha Tau Medical Ltd.

The PEG ratio compares a business's market value to its earnings growth rate, allowing for the identification of undervalued assets when the value is below one. Analyzing the price-to-earnings-to-growth ratio for Alpha Tau Medical Ltd. (DRTS) helps assess the extent to which the market discounts the potential of alpha therapy and team expansion, converting scientific expertise into real operational efficiency and a driver for share price growth.

Who Alpha Tau Medical Ltd. competes with

Price/Earnings to Growth Ratio NVCR (NovoCure Ltd)|PEG Multiple FBIO (Fortress)|PEG Multiple Acrivon Pharma ACRV|ALLR - Price/Earnings to Growth Ratio